These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 35131879

  • 1. Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening.
    Volesky KD, Magnan S, Mayrand MH, Isidean SD, El-Zein M, Comète E, Franco EL, Coutlée F.
    Cancer Epidemiol Biomarkers Prev; 2022 Apr 01; 31(4):851-857. PubMed ID: 35131879
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F, Du H, Wang C, Huang X, Wu R, CHIMUST team.
    PLoS One; 2020 Apr 01; 15(6):e0234518. PubMed ID: 32525936
    [Abstract] [Full Text] [Related]

  • 4. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Tao X, Zhang H, Zhang H, Xiao Y, Zhong F, Zhou X, Cong Q, Sui L, Zhao C.
    Cancer Cytopathol; 2022 Jul 01; 130(7):542-550. PubMed ID: 35312217
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
    Bukowski A, Hoyo C, Hudgens MG, Brewster WR, Valea F, Bentley RC, Vidal AC, Maguire RL, Schmitt JW, Murphy SK, North KE, Smith JS.
    Cancer Epidemiol Biomarkers Prev; 2022 Aug 02; 31(8):1564-1571. PubMed ID: 35654413
    [Abstract] [Full Text] [Related]

  • 8. Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial.
    Stoler MH, Parvu V, Yanson K, Andrews J, Vaughan L.
    Gynecol Oncol; 2023 Jul 02; 174():68-75. PubMed ID: 37149907
    [Abstract] [Full Text] [Related]

  • 9. DNA methylation testing with S5 for triage of high-risk HPV positive women.
    Adcock R, Nedjai B, Lorincz AT, Scibior-Bentkowska D, Banwait R, Torrez-Martinez N, Robertson M, Cuzick J, Wheeler CM, New Mexico HPV Pap Registry Steering Committee.
    Int J Cancer; 2022 Oct 01; 151(7):993-1004. PubMed ID: 35477862
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study.
    Hanley SJB, Fujita H, Aoyama-Kikawa S, Kasamo M, Torigoe T, Matsuno Y, Noriaki S, COMPACT study group.
    J Gynecol Oncol; 2021 Nov 01; 32(6):e86. PubMed ID: 34708593
    [Abstract] [Full Text] [Related]

  • 14. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
    Stoler MH, Wright TC, Parvu V, Yanson K, Cooper CK, Andrews J.
    Gynecol Oncol; 2019 Apr 01; 153(1):26-33. PubMed ID: 30638767
    [Abstract] [Full Text] [Related]

  • 15. Clinical Performance of hrHPV Primary Screening Using Vaginal versus Cervical Samples to Detect High-grade Intraepithelial Lesions.
    King J, Flores YN, Meneses-León J, Hernández-Salazar S, Robles-Rivera K, Rivera-Paredez B, León-Maldonado L, Hernández-López R, Torres-Ibarra L, Lazcano-Ponce E, Salmerón J.
    Cancer Prev Res (Phila); 2023 Dec 01; 16(12):681-687. PubMed ID: 37788346
    [Abstract] [Full Text] [Related]

  • 16. HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology.
    Stoler MH, Wright TC, Parvu V, Yanson K, Eckert K, Kodsi S, Cooper C.
    Am J Clin Pathol; 2019 Mar 01; 151(4):433-442. PubMed ID: 30649177
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
    Dong L, Wang MZ, Zhao XL, Feng RM, Hu SY, Zhang Q, Smith JS, Qiao YL, Zhao FH.
    Gynecol Oncol; 2018 Jan 01; 148(1):103-110. PubMed ID: 29169614
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Chang CL, Ho SC, Su YF, Juan YC, Huang CY, Chao AS, Hsu ZS, Chang CF, Fwu CW, Chang TC.
    Gynecol Oncol; 2021 May 01; 161(2):429-435. PubMed ID: 33757653
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.